QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

NASDAQ:QDEL • US2197981051

22.48 USD
-1.13 (-4.79%)
At close: Feb 20, 2026
22.48 USD
0 (0%)
After Hours: 2/20/2026, 8:00:41 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, QDEL scores 4 out of 10 in our fundamental rating. QDEL was compared to 185 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of QDEL while its profitability can be described as average. QDEL may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year QDEL was profitable.
  • In the past year QDEL had a positive cash flow from operations.
  • In multiple years QDEL reported negative net income over the last 5 years.
  • QDEL had a positive operating cash flow in 4 of the past 5 years.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B

1.2 Ratios

  • QDEL's Return On Assets of -20.78% is in line compared to the rest of the industry. QDEL outperforms 52.43% of its industry peers.
  • The Return On Equity of QDEL (-57.90%) is comparable to the rest of the industry.
  • QDEL has a Return On Invested Capital of 1.74%. This is in the better half of the industry: QDEL outperforms 67.03% of its industry peers.
  • QDEL had an Average Return On Invested Capital over the past 3 years of 1.38%. This is significantly below the industry average of 8.75%.
  • The last Return On Invested Capital (1.74%) for QDEL is above the 3 year average (1.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROIC 1.74%
ROA(3y)-17.23%
ROA(5y)-3.3%
ROE(3y)-42.63%
ROE(5y)-16.05%
ROIC(3y)1.38%
ROIC(5y)9.67%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 -60

1.3 Margins

  • Looking at the Operating Margin, with a value of 3.98%, QDEL is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
  • In the last couple of years the Operating Margin of QDEL has declined.
  • QDEL has a Gross Margin (47.15%) which is comparable to the rest of the industry.
  • QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 47.15%
OM growth 3Y-59.4%
OM growth 5Y-49.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.66%
GM growth 5Y-10.48%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QDEL is destroying value.
  • QDEL has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for QDEL has been increased compared to 5 years ago.
  • Compared to 1 year ago, QDEL has a worse debt to assets ratio.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.72, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
  • QDEL has a Altman-Z score (0.72) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.23 is on the high side and indicates that QDEL has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.23, QDEL is not doing good in the industry: 77.84% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.18
WACC9.55%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that QDEL should not have too much problems paying its short term obligations.
  • QDEL has a Current ratio of 1.78. This is in the lower half of the industry: QDEL underperforms 67.03% of its industry peers.
  • QDEL has a Quick Ratio of 1.78. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.98, QDEL is doing worse than 75.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.98
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • QDEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.59%, which is quite good.
  • Measured over the past years, QDEL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -36.12% on average per year.
  • QDEL shows a decrease in Revenue. In the last year, the revenue decreased by -1.89%.
  • The Revenue has been growing by 10.44% on average over the past years. This is quite good.
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
Revenue 1Y (TTM)-1.89%
Revenue growth 3Y-5.8%
Revenue growth 5Y10.44%
Sales Q2Q%2.23%

3.2 Future

  • QDEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.97% yearly.
  • Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 3.63% on average per year.
EPS Next Y20.65%
EPS Next 2Y25.68%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue Next Year2.46%
Revenue Next 2Y3.26%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.60 indicates a reasonable valuation of QDEL.
  • Compared to the rest of the industry, the Price/Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 94.59% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, QDEL is valued rather cheaply.
  • A Price/Forward Earnings ratio of 8.79 indicates a reasonable valuation of QDEL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 96.22% of the companies listed in the same industry.
  • QDEL is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.6
Fwd PE 8.79
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 96.22% of the companies in the same industry are more expensive than QDEL, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.62
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as QDEL's earnings are expected to grow with 23.97% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y25.68%
EPS Next 3Y23.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • QDEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

QUIDELORTHO CORP

NASDAQ:QDEL (2/20/2026, 8:00:41 PM)

After market: 22.48 0 (0%)

22.48

-1.13 (-4.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners123.47%
Inst Owner Change-1.09%
Ins Owners0.61%
Ins Owner Change1.68%
Market Cap1.53B
Revenue(TTM)2.73B
Net Income(TTM)-1.18B
Analysts74.29
Price Target38.18 (69.84%)
Short Float %15.53%
Short Ratio10.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)1.55%
PT rev (3m)-6.82%
EPS NQ rev (1m)-20.18%
EPS NQ rev (3m)-44.52%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)-7.29%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-1.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 10.6
Fwd PE 8.79
P/S 0.56
P/FCF N/A
P/OCF 40.94
P/B 0.75
P/tB N/A
EV/EBITDA 7.62
EPS(TTM)2.12
EY9.43%
EPS(NY)2.56
Fwd EY11.38%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY2.44%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.51
PEG (5Y)N/A
Graham Number37.81
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.78%
ROICexgc 3.88%
OM 3.98%
PM (TTM) N/A
GM 47.15%
FCFM N/A
ROA(3y)-17.23%
ROA(5y)-3.3%
ROE(3y)-42.63%
ROE(5y)-16.05%
ROIC(3y)1.38%
ROIC(5y)9.67%
ROICexc(3y)1.42%
ROICexc(5y)14.23%
ROICexgc(3y)4.43%
ROICexgc(5y)27.96%
ROCE(3y)1.75%
ROCE(5y)12.24%
ROICexgc growth 3Y-62.81%
ROICexgc growth 5Y-57.09%
ROICexc growth 3Y-55.09%
ROICexc growth 5Y-58.98%
OM growth 3Y-59.4%
OM growth 5Y-49.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.66%
GM growth 5Y-10.48%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA 4.57
Cap/Depr 43.31%
Cap/Sales 7%
Interest Coverage 250
Cash Conversion 6.82%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.98
Altman-Z 0.72
F-Score5
WACC9.55%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
EPS Next Y20.65%
EPS Next 2Y25.68%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.89%
Revenue growth 3Y-5.8%
Revenue growth 5Y10.44%
Sales Q2Q%2.23%
Revenue Next Year2.46%
Revenue Next 2Y3.26%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y4.34%
EBIT growth 3Y-61.76%
EBIT growth 5Y-44.75%
EBIT Next Year70.26%
EBIT Next 3Y24.99%
EBIT Next 5YN/A
FCF growth 1Y-57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.47%
OCF growth 3YN/A
OCF growth 5YN/A

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 4 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 7 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Undervalued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 4 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 10.6 and the Price/Book (PB) ratio is 0.75.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 20.65% in the next year.